In terms of glioma, although Nix can act as an effective tumor suppressor during early tumorigenesis of gliomas as previously reported [15], [18], [19], increased NIX mRNA levels may also be a molecular marker for the deterioration of glioma patients. Here, BNIP3L is linked to neoplasm.